Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treximet for probable migraine without aura
NCT00387881Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine without aura comparing Treximet with Placebo (2 arms). Primary endpoint: Pain-Free at 2 Hours Post-dose and Sustained Pain-Free From 2-24 Hours Post-dose. Started Sep 2006; status: completed.
02
Drugs
sumatriptan + naproxen sodium
03
Conditions
migraine without aura
Beyond the preview
Go deeper on NCT00387881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387881.